XELOX and XELIRI Alternative Regimen as First-line Treatment for Advanced Colorectal Cancer
Clinical trial NCT03511170 · UNKNOWN
Trial details
- NCT number
- NCT03511170
- Sponsor
- Harbin Medical University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-01
- Primary completion
- 2019-12-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.